NEW YORK, July 10, 2023 /PRNewswire/ — Attention Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Regeneron and certain of its officers and directors regarding potential securities…